Search
Filter by content type
Filter by content year
Filter by category
BioNTech and Fosun Pharma to Potentially Supply 10 Million Doses of BioNTech’s BNT162 mRNA-based Vaccine Candidate Against SARS-CoV-2 to Hong Kong SAR and Macao SAR
August 27, 2020 - … BioNTech and Fosun Pharma to Potentially Supply 10 Million Doses of … SARS-CoV-2 to Hong Kong SAR and Macao SAR … BioNTech and Fosun Pharma to Potentially Supply 10 Million Doses of … SARS-CoV-2 to Hong Kong SAR and Macao SAR BioNTech and Fosun Pharma to Potentially Supply 10 Million Doses of …
BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162
September 15, 2020 - … is being co-developed with its partners Pfizer Inc. and Fosun Pharma respectively. The goal of the initiative is the … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … is being co-developed with its partners Pfizer Inc. and Fosun Pharma respectively. The goal of the initiative is the …
BioNTech Announces Full Year 2019 Financial Results and Corporate Update
March 31, 2020 - … oncology pipeline and, along with our partners Pfizer and Fosun Pharma, aim to dose the first patient with our COVID-19 … shortly. BioNTech also announced a strategic alliance with Fosun Pharma to develop its COVID-19 vaccine in China. Under … China, conducting clinical trials in China and leveraging Fosun Pharma’s extensive clinical development, regulatory, …
BioNTech to Report Second Quarter 2022 Financial Results and Operational Update on August 8, 2022
July 25, 2022 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
BioNTech to Report Third Quarter 2022 Financial Results and Operational Update on November 7, 2022
October 24, 2022 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
BioNTech to Report Second Quarter 2023 Financial Results and Operational Update on August 7, 2023
July 24, 2023 - … global pharmaceutical collaborators, including DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, … global pharmaceutical collaborators, including DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, … global pharmaceutical collaborators, including DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, …
BioNTech to Report First Quarter 2023 Financial Results and Operational Update on May 8, 2023
April 24, 2023 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023
March 13, 2023 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
BioNTech to Report Third Quarter Financial Results and Operational Update on November 9, 2021
October 27, 2021 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
BioNTech to Report Second Quarter Financial Results and Operational Update on August 9, 2021
August 2, 2021 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …